Literature DB >> 2507536

Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein.

K Nagata1, H Itoh, T Katada, K Takenaka, M Ui, Y Kaziro, Y Nozawa.   

Abstract

We have purified, characterized, and identified two GTP-binding proteins with Mr of 25,000 (c25KG) and 21,000 (c21KG) from the cytosol fraction of human platelets. These two proteins were not copurified with the beta gamma subunits of heterotrimeric GTP-binding proteins. Amino acid sequences of tryptic fragments of c21KG completely matched with those of rap1 protein (Pizon, V., Chardin, P., Lerosey, I., Olofsson, B., and Tavitian, A. (1988) Oncogene 3, 201-204), smg p21 (Kawata, M., Matsui, Y., Kondo, J., Hishida, T., Teranishi, Y., and Takai, Y. (1988) J. Biol. Chem. 263, 18965-18971), and Krev-1 protein (Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., and Noda, M. (1989) Cell 56, 77-84). The partial amino acid sequence analysis of c25KG revealed that this protein was different from any low Mr GTP-binding proteins already reported. c25KG bound about 1 mol of [35S] guanosine 5'-(3-O-thio)triphosphate (GTP gamma S)/mol of protein, with a Kd value of about 45 nM. [35S]GTP gamma S-binding to c25KG was specifically inhibited by guanine nucleotides, GTP and GDP, but not by adenine nucleotides such as ATP and adenyl-5'-yl beta, gamma-imidodiphosphate. The binding activity was not inhibited by pretreatment with N-ethylmaleimide. c25KG hydrolyzed GTP to librate Pi with the specific activity of 1.8 mmol of Pi/mol of protein/min, which are different from the activities of the already purified low Mr GTP-binding proteins. We conclude that c25KG is a novel GTP-binding protein and c21KG is a rap1/smg p21/Krev-1 product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507536

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Tissue and subcellular distributions of the smg-21/rap1/Krev-1 proteins which are partly distinct from those of c-ras p21s.

Authors:  S Kim; A Mizoguchi; A Kikuchi; Y Takai
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 2.  New insights into the tumor metastatic process revealed by gene expression profiling.

Authors:  Patricia S Steeg
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

3.  Mitogenic and oncogenic properties of the small G protein Rap1b.

Authors:  D L Altschuler; F Ribeiro-Neto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

4.  Rapid degradation of dominant-negative Rab27 proteins in vivo precludes their use in transgenic mouse models.

Authors:  José S Ramalho; Ross Anders; Gesine B Jaissle; Mathias W Seeliger; Clare Huxley; Miguel C Seabra
Journal:  BMC Cell Biol       Date:  2002-10-28       Impact factor: 4.241

5.  Chromosomal mapping, gene structure and characterization of the human and murine RAB27B gene.

Authors:  J S Ramalho; T Tolmachova; A N Hume; A McGuigan; C Y Gregory-Evans; C Huxley; M C Seabra
Journal:  BMC Genet       Date:  2001-02-02       Impact factor: 2.797

6.  RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via 3-Hydroxy butyrate dehydrogenase 2 (BDH2).

Authors:  Can Meng; Li Huang; Xiangjun Fu; Bin Wu; Lie Lin
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  Rab27b regulates number and secretion of platelet dense granules.

Authors:  Tanya Tolmachova; Magnus Abrink; Clare E Futter; Kalwant S Authi; Miguel C Seabra
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-23       Impact factor: 11.205

8.  Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer.

Authors:  Hui Zhao; Qingqing Wang; Xudong Wang; Huijun Zhu; Shu Zhang; Wei Wang; Zhiwei Wang; Jianfei Huang
Journal:  Pancreas       Date:  2016-02       Impact factor: 3.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.